.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Citi
Chinese Patent Office
US Army
Novartis
Chubb
Accenture
UBS
QuintilesIMS

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074896

« Back to Dashboard

NDA 074896 describes CAPTOPRIL AND HYDROCHLOROTHIAZIDE, which is a drug marketed by G And W Labs Inc, Ivax Sub Teva Pharms, Mylan, Vintage Pharms Llc, and Watson Labs, and is included in five NDAs. It is available from two suppliers. Additional details are available on the CAPTOPRIL AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in CAPTOPRIL AND HYDROCHLOROTHIAZIDE is captopril; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.

Summary for 074896

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 074896

Ingredient-typeThiazides
Mechanism of ActionAngiotensin-converting Enzyme Inhibitors
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 074896

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896 ANDA Mylan Phamaceuticals Inc. 0378-0081 0378-0081-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0081-01)
CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896 ANDA Mylan Phamaceuticals Inc. 0378-0083 0378-0083-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0083-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;15MG
Approval Date:Dec 29, 1997TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;25MG
Approval Date:Dec 29, 1997TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG;25MG
Approval Date:Dec 29, 1997TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Cantor Fitzgerald
Cerilliant
QuintilesIMS
Teva
Daiichi Sankyo
McKinsey
Moodys
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot